BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
No Form 4 insider filings for BRTX were recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR · 0001505497 (2026-04-11) ↗